TipRanks
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market
RGBP
Regen Biopharma
RESEARCH TOOLSreports

Regen Biopharma (RGBP) Financial Statements

122 Followers

Regen Biopharma Financial Overview

Regen Biopharma's market cap is currently $194.64K. The company's EPS TTM is $-0.0198; its P/E ratio is >-0.01; Regen Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total Revenue$ 236.56K$ 236.56K$ 236.56K$ 235.52K$ 171.19K
Gross Profit$ 236.56K$ 236.56K$ 236.56K$ 185.52K$ 146.19K
Operating Income$ -338.54K$ -417.00K$ -687.00K$ -340.00K$ -201.00K
EBITDA$ -1.01M$ -418.00K$ 3.12M$ 2.99M$ -6.20M
Net Income$ -1.27M$ -668.00K$ 1.02M$ 2.23M$ -6.76M
Balance Sheet
Cash & Short-Term Investments$ 716.00$ 716.00$ 121.04K$ 51.20K$ 727.16K
Total Assets$ 274.63K$ 177.61K$ 353.62K$ 559.00K$ 1.21M
Total Debt$ 793.70K$ 814.70K$ 756.20K$ 1.27M$ 3.58M
Net Debt$ 792.98K$ 813.98K$ 635.17K$ 1.22M$ 2.86M
Total Liabilities$ 6.56M$ 5.37M$ 5.46M$ 8.60M$ 14.70M
Stockholders' Equity$ -6.28M$ -5.19M$ -5.10M$ -8.04M$ -13.49M
Cash Flow
Free Cash Flow$ -383.59K$ -693.14K$ -173.92K$ -606.92K$ -1.13M
Operating Cash Flow$ -383.59K$ -693.14K$ -173.92K$ -606.92K$ -1.13M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 25.00K$ 495.00K
Financing Cash Flow$ 452.43K$ 572.82K$ 243.75K$ -94.04K$ 1.36M
Currency in USD

Regen Biopharma Earnings and Revenue History

Income Statement >

Regen Biopharma Debt to Assets

Balance Sheet >

Regen Biopharma Cash Flow

Cash Flow >

Regen Biopharma Forecast EPS vs Actual EPS

Earnings >